These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


680 related items for PubMed ID: 6998023

  • 21. [New aspects of chemotherapy of tuberculosis].
    Khomenko AG.
    Probl Tuberk; 1980 Jul; (7):14-9. PubMed ID: 7413630
    [No Abstract] [Full Text] [Related]

  • 22. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ, Kwon OJ, Park YK, Lew WJ, Bai GH.
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Modern treatment of tuberculosis.
    Dutt AK, Stead WW.
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract] [Full Text] [Related]

  • 26. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
    Aquinas M.
    Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
    Bobarykin VS.
    Probl Tuberk; 1991 Dec; (10):53-5. PubMed ID: 1788233
    [No Abstract] [Full Text] [Related]

  • 29. [Short-term chemotherapy of tuberculosis. Cooperative French trial].
    Pretet S.
    Rev Fr Mal Respir; 1983 Dec; 11(6):859-66. PubMed ID: 6366945
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [A study on the intensive chemotherapy for previously untreated pulmonary tuberculosis--comparison of two regimens, SM-INH-RFP and SM-INH-EB (author's transl)].
    Maekawa N, Kuze F, Inaba N, Ohi Y, Yamada E, Yasubuchi Y.
    Kekkaku; 1977 Jun; 52(6):299-306. PubMed ID: 904139
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 39. [Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):219-26. PubMed ID: 5449509
    [No Abstract] [Full Text] [Related]

  • 40. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C, Bercea O, Barcan F, Stinghe R, Dinulică E, Marcovici M, Cristea M, Cărpinişan L, Gheorghiu M, Iancovici O, Ghinescu S.
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.